Statistics
Publications
16
Citations
3.2K
H-Index
16
Active since
2010
Quinlan Sievers is an author at Dana-Farber Cancer Institute specializing in life sciences, molecular biology, and molecular oncology.
Publications per year
2010–2024
16
16
<i>SF3B1</i> and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
Lili Wang, Michael S. Lawrence, Youzhong Wan et al. · New England Journal of Medicine · 2011 · 1.1K citations · Full text
Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN
Quinlan Sievers, Georg Petzold, R.D. Bunker et al. · Science · 2018 · 532 citations · Full text
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K
Mikołaj Słabicki, Zuzanna Kozicka, Georg Petzold et al. · Nature · 2020 · 407 citations · Full text
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide
Max Jan, Irene Scarfò, Rebecca C. Larson et al. · Science Translational Medicine · 2021 · 258 citations · Full text
Medicine, Oncology, Pharmacology +17
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127
Skye Montoya, Jessie Bourcier, Mark Noviski et al. · Science · 2024 · 148 citations · Full text
1–5 of 16